Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II trial
转移性去势抵抗性前列腺癌患者接受卡博替尼治疗后血浆生物标志物的变化：一项 II 期试验扩展队列的事后分析
期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-015-0747-y
Leibowitz-Amit, Raya; Pintilie, Melania; Khoja, Leila; Azad, Arun A; Berger, Raanan; Laird, A Douglas; Aftab, Dana T; Chi, Kim N; Joshua, Anthony M
